Lineage Cell Therapeutics
LCTX
#8742
Rank
$0.11 B
Marketcap
$0.54
Share price
-1.91%
Change (1 day)
-51.96%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : $32.71 Million USD

According to Lineage Cell Therapeutics 's latest financial reports the company has $32.71 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$35.49 M-38.67%
2022-12-31$57.87 M-0.83%
2021-12-31$58.35 M40.41%
2020-12-31$41.56 M35.31%
2019-12-31$30.71 M-0.08%
2018-12-31$30.74 M-19.47%
2017-12-31$38.17 M68.06%
2016-12-31$22.71 M-47.15%
2015-12-31$42.98 M45.75%
2014-12-31$29.49 M436.62%
2013-12-31$5.49 M26.33%
2012-12-31$4.34 M-80.42%
2011-12-31$22.21 M-33.35%
2010-12-31$33.32 M173.4%
2009-12-31$12.18 M99167.7%
2008-12-31$0.01 M29.24%
2007-12-31$0 M-98.31%
2006-12-31$0.56 M-69.41%
2005-12-31$1.83 M33.78%
2004-12-31$1.37 M91.13%
2003-12-31$0.71 M-44.16%
2002-12-31$1.28 M-22.29%
2001-12-31$1.65 M25.37%
2000-12-31$1.31 M-75.09%
1999-12-31$5.29 M120.53%
1998-12-31$2.4 M
1998-06-30$4.1 M-47.44%
1997-06-30$7.8 M225%
1996-06-30$2.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.27 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA